Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • 11 Drugs Controller...

    11 Drugs Controller Officers appointed in Punjab; Details

    Farhat NasimWritten by Farhat Nasim Published On 2020-01-02T15:46:18+05:30  |  Updated On 2 Jan 2020 3:46 PM IST

    "Now with the recruitment of these 11 drugs controller officers, the FDA would expedite the action against the chemists who are indulging in unethical trading of drugs and further the quality of medicines available in the market will also improve," Health Minister Balbir Singh Sidhu said.


    Chandigarh: To further improve the functioning of Punjab's Food and Drug Administration Department (FDA), Health Minster Balbir Singh Sidhu on Wednesday handed over the appointment letters to 11 drugs controller officers.


    "Punjab government has celebrated the New Year by appointing youngsters on the important posts. The FDA has already 48 drugs controller officers in place and now the strength would go up to 60 sanctioned posts," Sidhu as quoted by ANI.


    He added that the FDA is conducting the regular inspection of wholesale and retail sale drugs licenses across the state with a view to keep a tab on the illegal sale of habit forming drugs.


    "Now with the recruitment of these 11 drugs controller officers, the FDA would expedite the action against the chemists who are indulging in unethical trading of drugs and further the quality of medicines available in the market will also improve," Sidhu further added.




    Health Minster Balbir Singh Sidhu today handed over the appointment letters to 11 Drugs Controller Officers to further improve the functioning of Food & Drug Administration Department (FDA) Punjab. pic.twitter.com/niyiNFdQsf


    — Government of Punjab (@PunjabGovtIndia) January 1, 2020


    Also Read: Punjab: Chemist shot for denying habit-forming drug to a patient


    The Minister further said that to reduce the pendency of analysis of samples at CEL (Chemical Examiner Lab) in Kharar, five analysts and four MLTs have also inducted in the department.


    Sidhu also said that around 4,000 recruitments of medical and paramedical and other clerical and ministerial staff had been made in the department, which has resulted in extensive improvement in government hospital performance.


    The Minister added that the Union Government had given the target to Punjab for converting the 2,950 sub-centres into health and wellness centres by 2023 while with the tireless efforts of Punjab government it would be achieved by 2021.


    He informed that advertisement to recruit 1,000 community health officers (CHOs) has been issued and about 928 CHOs have already been inducted so far.


    "690 more CHOs would be joining at the health and wellness centres till March 2020 after the completion of their professional course," he added.


    Also Read: Punjab Govt suspends licence of 1000 chemists for violation of guidelines
    appointment lettersbalbir singh sidhuchemical examiner labdrug controller officerHealth MinisterPunjabunion govt
    Source : with agency inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok